Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Eptifibatide (Integrilin)].
Holmvang L, Grande P. Holmvang L, et al. Ugeskr Laeger. 2001 Jan 22;163(4):468-72. Ugeskr Laeger. 2001. PMID: 11218791 Danish.
[The patient with cardiac disease].
Wetterslev J, Holmvang L. Wetterslev J, et al. Among authors: holmvang l. Ugeskr Laeger. 2006 Dec 4;168(49):4305-9. Ugeskr Laeger. 2006. PMID: 17164059 Danish.
Drug-eluting versus bare metal stents in patients with st-segment-elevation myocardial infarction: eight-month follow-up in the Drug Elution and Distal Protection in Acute Myocardial Infarction (DEDICATION) trial.
Kelbaek H, Thuesen L, Helqvist S, Clemmensen P, Kløvgaard L, Kaltoft A, Andersen B, Thuesen H, Engstrøm T, Bøtker HE, Saunamäki K, Krusell LR, Jørgensen E, Hansen HH, Christiansen EH, Ravkilde J, Køber L, Kofoed KF, Terkelsen CJ, Lassen JF; DEDICATION Investigators. Kelbaek H, et al. Circulation. 2008 Sep 9;118(11):1155-62. doi: 10.1161/CIRCULATIONAHA.107.758698. Epub 2008 Aug 25. Circulation. 2008. PMID: 18725489 Clinical Trial.
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction.
Lønborg J, Vejlstrup N, Kelbæk H, Bøtker HE, Kim WY, Mathiasen AB, Jørgensen E, Helqvist S, Saunamäki K, Clemmensen P, Holmvang L, Thuesen L, Krusell LR, Jensen JS, Køber L, Treiman M, Holst JJ, Engstrøm T. Lønborg J, et al. Among authors: holmvang l. Eur Heart J. 2012 Jun;33(12):1491-9. doi: 10.1093/eurheartj/ehr309. Epub 2011 Sep 14. Eur Heart J. 2012. PMID: 21920963 Clinical Trial.
Influence of pre-infarction angina, collateral flow, and pre-procedural TIMI flow on myocardial salvage index by cardiac magnetic resonance in patients with ST-segment elevation myocardial infarction.
Lønborg J, Kelbæk H, Vejlstrup N, Bøtker HE, Kim WY, Holmvang L, Jørgensen E, Helqvist S, Saunamäki K, Thuesen L, Krusell LR, Clemmensen P, Engstrøm T. Lønborg J, et al. Among authors: holmvang l. Eur Heart J Cardiovasc Imaging. 2012 May;13(5):433-43. doi: 10.1093/ejechocard/jer296. Epub 2011 Dec 29. Eur Heart J Cardiovasc Imaging. 2012. PMID: 22207343
Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study.
Lønborg JT, Engstrøm T, Møller JE, Ahtarovski KA, Kelbæk H, Holmvang L, Jørgensen E, Helqvist S, Saunamäki K, Søholm H, Andersen M, Mathiasen AB, Kühl JT, Clemmensen P, Køber L, Vejlstrup N. Lønborg JT, et al. Among authors: holmvang l. Eur Heart J Cardiovasc Imaging. 2013 Feb;14(2):118-27. doi: 10.1093/ehjci/jes118. Epub 2012 Jun 12. Eur Heart J Cardiovasc Imaging. 2013. PMID: 22696494 Clinical Trial.
A single center, open, randomized study investigating the clinical safety and the endothelial modulating effects of a prostacyclin analog in combination with eptifibatide in patients having undergone primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction.
Holmvang L, Ostrowski SR, Dridi NP, Johansson P. Holmvang L, et al. Prostaglandins Other Lipid Mediat. 2012 Dec;99(3-4):87-95. doi: 10.1016/j.prostaglandins.2012.08.002. Epub 2012 Aug 28. Prostaglandins Other Lipid Mediat. 2012. PMID: 22951358 Clinical Trial.
239 results